Adverse Interaction between Capecitabine and Warfarin Resulting in Altered Coagulation Parameters: A Review of the Literature Starting from a Case Report
Capecitabine is an orally active prodrug of fluorouracil and is extensively used as an antineoplastic agent. It is converted to 5-Fluorouracil in the liver and tumor tissues. Warfarin is an anticoagulant agent for preventing and treating venous and arterial thrombosis and embolism and is metabolized...
Saved in:
| Main Author: | Giovanni Giunta |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2010-01-01
|
| Series: | Case Reports in Medicine |
| Online Access: | http://dx.doi.org/10.1155/2010/426804 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Naoxintong Is Involved in the Coagulation Regulation of Warfarin Through the MAPK Pathway
by: Luo X, et al.
Published: (2025-01-01) -
Decrease in Efficacy of Warfarin as a Result of Drug-Drug Interaction (Case Report)
by: N. T. Vatutin, et al.
Published: (2020-03-01) -
Platelet and coagulation hemostasis status in patients with atrial fibrillation depending on warfarin dosing method
by: M. Yu. Kolesnyk, et al.
Published: (2022-12-01) -
Adverse drug events associated with capecitabine: a real-world pharmacovigilance study based on the FAERS database
by: Rongqiang Liu, et al.
Published: (2024-12-01) -
A Case of Gastrointestinal Hemorrage Due to Warfarin Interaction with Nalidixic Acid Resulting in Massive Blood Loss
by: D. A. Sychev, et al.
Published: (2020-05-01)